Jeffrey P. Mornhinweg

Array ( [id] => 8975934 [patent_doc_number] => 20130209364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'Anti-Viral Azide Containing Compounds' [patent_app_type] => utility [patent_app_number] => 13/812533 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16919 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13812533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8828701 [patent_doc_number] => 20130129747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'CROSS-PROTECTIVE PATHOGEN PROTECTION, METHODS AND COMPOSITIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/811467 [patent_app_country] => US [patent_app_date] => 2011-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 34501 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8094233 [patent_doc_number] => 20120082693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'USE OF PROTEINS AND PEPTIDES ENCODED BY THE GENOME OF A NOVEL SARS-ASSOCIATED CORONAVIRUS STRAIN' [patent_app_type] => utility [patent_app_number] => 13/187011 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 116 [patent_figures_cnt] => 116 [patent_no_of_words] => 45323 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13187011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742336 [patent_doc_number] => 20120020995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'PARAPOXVIRUS VECTORS' [patent_app_type] => utility [patent_app_number] => 13/185561 [patent_app_country] => US [patent_app_date] => 2011-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13518 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020995.pdf [firstpage_image] =>[orig_patent_app_number] => 13185561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8197146 [patent_doc_number] => 20120121633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'HIV CD4 BINDING SITE BASED COVALENT IMMUNOGEN COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/184530 [patent_app_country] => US [patent_app_date] => 2011-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 29308 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20120121633.pdf [firstpage_image] =>[orig_patent_app_number] => 13184530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13140205 [patent_doc_number] => 10087423 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-02 [patent_title] => Method for harvesting expression products [patent_app_type] => utility [patent_app_number] => 13/811093 [patent_app_country] => US [patent_app_date] => 2011-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19681 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8277789 [patent_doc_number] => 20120171660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'METHOD FOR SCREENING AND PURIFYING ENTEROVIRUS, METHOD FOR MASS-PRODUCING ENTEROVIRUS, AND METHOD FOR MANUFACTURING ENTEROVIRUS VACCINE' [patent_app_type] => utility [patent_app_number] => 13/182702 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4734 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13182702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7719861 [patent_doc_number] => 20120009196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'MONOCLONAL ANTIBODIES AGAINST HEPATITIS C VIRUS CORE PROTEIN' [patent_app_type] => utility [patent_app_number] => 13/178810 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 46670 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20120009196.pdf [firstpage_image] =>[orig_patent_app_number] => 13178810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8767098 [patent_doc_number] => 20130095135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'PROCESS FOR REMOVING ADVENTITIOUS AGENTS DURING THE PRODUCTION OF A VIRUS IN CELL CULTURE' [patent_app_type] => utility [patent_app_number] => 13/805397 [patent_app_country] => US [patent_app_date] => 2011-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15278 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13805397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8903683 [patent_doc_number] => 20130171185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'NOROVIRUS DERIVED IMMUNOGENIC COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/808157 [patent_app_country] => US [patent_app_date] => 2011-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 70578 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7710302 [patent_doc_number] => 20120003255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'FLAVIVIRUS HOST-RANGE MUTATIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/173895 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16528 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13173895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8891552 [patent_doc_number] => 20130164736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'METHOD FOR DETECTING MOLECULAR INTERACTIONS' [patent_app_type] => utility [patent_app_number] => 13/808077 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11377 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066109 [patent_doc_number] => 20110243971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Vaccines' [patent_app_type] => utility [patent_app_number] => 13/162134 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11340 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243971.pdf [firstpage_image] =>[orig_patent_app_number] => 13162134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8884074 [patent_doc_number] => 20130157258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'HCV NS5B PROTEASE MUTANTS' [patent_app_type] => utility [patent_app_number] => 13/704107 [patent_app_country] => US [patent_app_date] => 2011-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28153 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662318 [patent_doc_number] => 20110311587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'Fusogenic virus-like particles and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/134266 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13643 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311587.pdf [firstpage_image] =>[orig_patent_app_number] => 13134266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9003120 [patent_doc_number] => 20130224245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'CONCENTRATION OF VACCINE ANTIGENS WITHOUT LYOPHILIZATION' [patent_app_type] => utility [patent_app_number] => 13/700436 [patent_app_country] => US [patent_app_date] => 2011-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13361 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13700436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8828631 [patent_doc_number] => 20130129676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'COMBINATION OF ANTI-ENVELOPE ANTIBODIES AND ANTI-RECEPTOR ANTIBODIES FOR THE TREATMENT AND PREVENTION OF HCV INFECTION' [patent_app_type] => utility [patent_app_number] => 13/699060 [patent_app_country] => US [patent_app_date] => 2011-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15099 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7566988 [patent_doc_number] => 20110287051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'PARAPOXVIRUS VECTORS' [patent_app_type] => utility [patent_app_number] => 13/111020 [patent_app_country] => US [patent_app_date] => 2011-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12858 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20110287051.pdf [firstpage_image] =>[orig_patent_app_number] => 13111020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8659114 [patent_doc_number] => 20130039943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'NOVEL METHOD' [patent_app_type] => utility [patent_app_number] => 13/643565 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14898 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13643565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9551716 [patent_doc_number] => 08758762 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Method for preparing recombinant antigen complex using rotavirus nanoparticle' [patent_app_type] => utility [patent_app_number] => 13/095303 [patent_app_country] => US [patent_app_date] => 2011-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8336 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13095303 [rel_patent_id] =>[rel_patent_doc_number] =>)